← Toate temele

Anxietate

Îngrijorare excesivă, tensiune, atacuri de panică.

73 de articole
Definiții și semne precoce · în curândGhiduri practice · în curândTeste orientative · în curândResurse pentru specialiști · în curând
StudiuAnxietateÎncredere înaltă17.06.2026

Resting-State Functional Connectivity Differences Between Generalized Anxiety Disorder and Social Anxiety Disorder: Nucleus Accumbens and Thalamus Networks

This fMRI study compared brain functional connectivity in 21 social anxiety disorder (SAD) patients, 17 generalized anxiety disorder (GAD) patients, and 30 healthy controls, finding that GAD involves stronger connectivity between the nucleus accumbens and thalamus compared to SAD. The nucleus accumbens-thalamus connectivity correlated with state anxiety severity in both anxiety groups, suggesting this network distinction may help differentiate between these two conditions.

StudiuAnxietateÎncredere bună17.06.2026

Differential Item Functioning in Mood and Anxiety Disorder Screening Questions Across Demographic Subgroups

This study analyzed screening questions from the Composite International Diagnostic Interview in 15,893 Australian survey respondents to assess whether the accuracy of mood and anxiety disorder screening varies by sex, age, employment, location, and substance use. While some differential item functioning was identified primarily by age and sex, the overall impact on screening accuracy for mood and anxiety disorders was minimal.

StudiuAnxietateÎncredere bună17.06.2026

Videonystagmography Findings in Dizziness Patients with Anxiety Disorders

A hospital-based study of 64 anxiety patients presenting with dizziness examined vestibular function using videonystagmography and assessed anxiety severity with the Hamilton Anxiety Rating Scale. The study found statistically significant associations between anxiety disorders and vestibular dysfunction, with abnormal gaze nystagmus and peripheral vestibulopathy occurring in substantial proportions of patients.

StudiuAnxietateÎncredere bună17.06.2026

The Regulatory Role and Mechanism of BNST in Anxiety Disorder

This review examines how the bed nucleus of the stria terminalis (BNST) regulates anxiety through multiple neural circuits and subregions that modulate stress response. It discusses molecular mechanisms, neural pathways involved in anxiety genesis, and how modern neuroimaging techniques like fMRI and PET are advancing understanding of BNST's therapeutic potential.

StudiuAnxietateÎncredere bună16.06.2026

Case Report: Generalized Anxiety Disorder and Hypertension—Bidirectional Relationship Addressed Through Integrated Management

A 61-year-old patient with treatment-resistant hypertension and anxiety following thyroidectomy was treated with a multimodal approach combining antidepressants, transcranial magnetic stimulation, biofeedback, and psychotherapy, achieving significant reductions in blood pressure (176/105 to 125/72 mmHg) and anxiety severity. The case illustrates the bidirectional neuroendocrine relationship between anxiety and hypertension, with improvements sustained at 6-month follow-up and reduced antihypertensive medication requirements.

StudiuAnxietateÎncredere bună16.06.2026

High-Intensity Mindfulness and Cognitive Behavioral Group Therapy for Social Anxiety Disorder: Preliminary Efficacy

A pilot study of 10 participants with social anxiety disorder received an eight-session group therapy combining mindfulness training with cognitive-behavioral techniques including cognitive restructuring and exposure exercises. Participants showed significant improvements in anxiety symptoms, cost/probability biases, depression, and mindfulness skills with large effect sizes, though the small sample and lack of control group require larger studies for confirmation.

StudiuAnxietateÎncredere bună16.06.2026

Clinical relevance of venlafaxine ER for generalized anxiety disorder

A critical review of venlafaxine's efficacy in generalized anxiety disorder notes that while a randomized controlled trial showed statistical significance, the magnitude of improvement may lack clinical meaningfulness. Methodological limitations including placebo responder exclusion, comorbid depression inclusion, and high discontinuation rates due to adverse events question the medication's practical risk-benefit profile.

StudiuAnxietateÎncredere bună16.06.2026

Weight Control Methods and Risk of Generalized Anxiety Disorder Among Korean Adults

This nationally representative study of 3,251 Korean adults found a dose-response relationship between the number of weight control methods used and anxiety symptoms (GAD-7 scores). Specific methods including fasting, over-the-counter diet pills, supplements, and mono-diets were associated with elevated anxiety risk, particularly among underweight or normal-weight individuals.

StudiuAnxietateÎncredere bună16.06.2026

Social well-being moderates behavioral therapy response for generalized anxiety disorder

A secondary analysis of a randomized trial (N=69) examined whether social support and isolation/loneliness moderate treatment outcomes for GAD in behavioral activation versus exposure therapy. Lower baseline social support predicted better response to behavioral activation but worse response to exposure therapy, suggesting social factors may guide personalized treatment selection for anxiety.

StudiuAnxietateÎncredere bună16.06.2026

Distinguishing Quantitative Electroencephalogram Findings between Panic Disorder and Generalized Anxiety Disorder

This study investigates differences in quantitative EEG (qEEG) patterns between panic disorder and generalized anxiety disorder to identify potential biomarkers for distinguishing these anxiety conditions. The research uses established neuroimaging methodology to explore objective neurological correlates of different anxiety disorder presentations.

StudiuAnxietateÎncredere bună16.06.2026

Neurosteroids as a prospective treatment for Social Anxiety Disorder

This research examines neurosteroids—endogenous steroid compounds that modulate neural function—as a potential therapeutic approach for social anxiety disorder. The work represents legitimate scientific inquiry into novel pharmacological mechanisms, though clinical effectiveness requires robust evidence from controlled trials.

StudiuAnxietateÎncredere bună16.06.2026

Efficacy of Anzeilax, a Smartphone-Based Digital Therapeutic for Generalized Anxiety Disorder: A Randomized Controlled Trial

A 10-week randomized controlled trial evaluated Anzeilax, an acceptance and commitment therapy-based digital app incorporating self-talk to enhance psychological flexibility, versus treatment as usual in 96 participants with generalized anxiety disorder. Primary and secondary outcomes measured anxiety symptoms, worry, and depression using validated clinical scales (GAD-7, BAI, PSWQ, HADS).

StudiuAnxietateÎncredere înaltă16.06.2026

Intact but vulnerable: Affective working memory in social anxiety disorder

This review examines how emotionally and socially threatening stimuli impair working memory processes in people with social anxiety disorder, showing that while general working memory capacity may be intact, deficits emerge specifically when tasks involve threat-related content or require executive control under stress. The authors propose affective working memory as a core mechanism linking cognitive, emotional, and social dysfunction in SAD and recommend targeted assessments and interventions focusing on emotion regulation.

StudiuAnxietateÎncredere înaltă16.06.2026

Affective Dynamics and Emotional Reactivity in Social Anxiety Disorder

This study used Ecological Momentary Assessment to examine mood patterns in 236 adults with social anxiety disorder (SAD), other anxiety disorders, and controls across two weeks of daily life. People with SAD showed elevated baseline anxiety and sadness, greater mood improvements after positive events, and heightened anxiety responses to negative non-social events, suggesting emotional reactivity extends beyond social situations.

StudiuAnxietateÎncredere înaltă16.06.2026

Antipsychotic and mood stabilizer prescribing for Veterans Affairs patients with PTSD: A national investigation

This study examined prescribing patterns of antipsychotics and mood stabilizers among 122,292 VA patients diagnosed with PTSD without comorbid bipolar or psychotic disorders in 2019. Findings showed 11.9% received antipsychotics and 12.4% received mood stabilizers, with suicide risk flags and benzodiazepine use as key predictors, highlighting guideline-nonconcordant treatment patterns in the VA system.